Medicines Marketed by Concord Biotech Ltd

About Concord Biotech Ltd

Concord Biotech Ltd, established in 2000, is a leading biotechnology and pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company specialises in the research, development, manufacturing, marketing, and selling of a wide range of pharmaceutical products. With a strong global presence, Concord Biotech Ltd caters to consumers in more than 70 countries worldwide, including key markets in the USA, Europe, Japan, Latin America, Africa, Asia, and India.

Concord Biotech Ltd operates three state-of-the-art manufacturing facilities near Ahmedabad, Gujarat, which are dedicated to the production of Active Pharmaceutical Ingredients (APIs) and finished formulations. These facilities have been inspected and approved by major regulatory bodies, ensuring that the company's products meet the highest standards of quality and safety.

Concord Biotech Ltd Products

Concord Biotech Ltd offers a comprehensive portfolio of pharmaceutical products, focusing primarily on APIs and finished formulations. The company's API range includes products across various therapeutic segments, such as immunosuppressants, antibacterial, oncology, and antifungals. These APIs are produced through advanced fermentation and semi-synthetic processes. Some of the most popular API products include Mycophenolate Mofetil, Cyclosporine, Sirolimus, Vancomycin Hydrochloride, and Fidaxomicin.

In addition to APIs, Concord Biotech Ltd manufactures finished formulations, including oral solids (tablets and capsules) and oral liquids (solutions and suspensions). The company is also developing capabilities for injectable formulations, such as liquid, lyophilised, and dry powder injectables. Concord Biotech Ltd's commitment to research and development, coupled with its adherence to global regulatory standards and Good Manufacturing Practices (GMP), ensures that its products are of the highest quality and reliability, providing effective treatments for patients worldwide.